Harel Insurance Investments & Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Buy
7,576
+1,608
+27% +$375K 0.01% 171
2026
Q1
$1.46M Buy
5,968
+3,481
+140% +$811K 0.01% 149
2025
Q4
$512K Sell
2,487
-4,095
-62% -$810K ﹤0.01% 213
2025
Q3
$1.22M Buy
6,582
+5,991
+1,014% +$1.03M 0.01% 188
2025
Q2
$90K Sell
591
-127
-18% -$19.5K ﹤0.01% 323
2025
Q1
$119K Buy
718
+200
+39% +$31.3K ﹤0.01% 305
2024
Q4
$75K Sell
518
-811
-61% -$126K ﹤0.01% 274
2024
Q3
$215K Buy
1,329
+326
+33% +$51.9K ﹤0.01% 220
2024
Q2
$147K Sell
1,003
-62
-6% -$9.22K ﹤0.01% 277
2024
Q1
$168K Sell
1,065
-240
-18% -$38.2K ﹤0.01% 263
2023
Q4
$204K Hold
1,305
﹤0.01% 289
2023
Q3
$203K Sell
1,305
-5,143
-80% -$849K ﹤0.01% 306
2023
Q2
$1.06M Sell
6,448
-1,342
-17% -$217K 0.03% 149
2023
Q1
$1.2M Buy
7,790
+660
+9% +$107K 0.02% 159
2022
Q4
$1.26M Buy
7,130
+165
+2% +$28.5K 0.03% 147
2022
Q3
$1.15M Sell
6,965
-18,515
-73% -$3.13M 0.03% 162
2022
Q2
$4.52M Sell
25,480
-3,370
-12% -$600K 0.1% 103
2022
Q1
$5.11M Sell
28,850
-16,240
-36% -$2.76M 0.08% 107
2021
Q4
$7.76M Buy
45,090
+2,037
+5% +$333K 0.15% 73
2021
Q3
$6.95M Buy
43,053
+33,488
+350% +$5.71M 0.18% 57
2021
Q2
$5.09M Sell
9,565
-3,211
-25% -$532K 0.11% 88
2021
Q1
$6.95M Buy
12,776
+69
+0.5% +$11.2K 0.13% 90
2020
Q4
$6.32M Sell
12,707
-15,545
-55% -$2.29M 0.15% 73
2020
Q3
$4.21M Buy
28,252
+25,412
+895% +$3.76M 0.14% 59
2020
Q2
$399K Sell
2,840
-910
-24% -$133K 0.01% 152
2020
Q1
$492K Buy
3,750
+222
+6% +$31.5K 0.02% 102
2019
Q4
$515K Buy
3,528
+3,348
+1,860% +$454K 0.02% 124
2019
Q3
$23K Sell
180
-5,197
-97% -$685K ﹤0.01% 378
2019
Q2
$749K Buy
5,377
+2,870
+114% +$397K 0.04% 89
2019
Q1
$350K Buy
2,507
+2,380
+1,874% +$319K 0.02% 93
2018
Q4
$16K Sell
127
-53
-29% -$7.39K ﹤0.01% 394
2018
Q3
$25K Buy
180
+53
+42% +$7.04K ﹤0.01% 410
2018
Q2
$15K Sell
127
-710
-85% -$88.6K ﹤0.01% 411
2018
Q1
$107K Sell
837
-1,200
-59% -$162K 0.01% 257
2017
Q4
$285K Sell
2,037
-1,453
-42% -$202K 0.02% 182
2017
Q3
$454K Sell
3,490
-349
-9% -$46.3K 0.04% 100
2017
Q2
$508K Buy
3,839
+2,649
+223% +$338K 0.04% 102
2017
Q1
$149K Buy
1,190
+841
+241% +$100K 0.01% 185
2016
Q4
$40K Buy
349
+147
+73% +$17K 0.01% 214
2016
Q3
$24K Sell
202
-5,214
-96% -$633K ﹤0.01% 285
2016
Q2
$657K Buy
5,416
+5,214
+2,581% +$592K 0.08% 75
2016
Q1
$22K Buy
+202
New +$20.9K ﹤0.01% 264

Other funds holding JNJ

Harel Insurance Investments & Financial Services's JNJ Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services increased its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, buying an estimated $375K and bringing the position to 7,576 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #171.

Harel Insurance Investments & Financial Services first reported a position in JNJ in Q1 2016 and has held it in 42 quarters since. The position peaked at $7.76M in Q4 2021. 3,344 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 7,576 shares of Johnson & Johnson worth $1.92M as of Q2 2026.
  • Harel Insurance Investments & Financial Services bought 1,608 Johnson & Johnson shares in Q2 2026, an estimated $375K.
  • Johnson & Johnson made up 0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #171 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Johnson & Johnson in Q1 2016 and has held it in 42 quarters since.
  • Harel Insurance Investments & Financial Services's Johnson & Johnson position peaked at $7.76M in Q4 2021.
  • 3,344 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.